CARsgen's CAR-T Product Satri-cel Included in China's Commercial Health Insurance Innovative Drug List ...Middle East

SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that satricabtagene autoleucel ("satri-cel", product code: CT041), an autologous CAR T-cell therapy product...

Hence then, the article about carsgen s car t product satri cel included in china s commercial health insurance innovative drug list was published today ( Saturday 14/11/2026 - 01:06 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CARsgen's CAR-T Product Satri-cel Included in China's Commercial Health Insurance Innovative Drug List )

Also on site :

• US behaving like ‘mafia boss’ in Middle East – NGO founder (VIDEO)
• The DC Studios To-Do List: Here’s What Incoming Boss Jeremy Latcham Will Sort Through From The Gunn-Safran Era
• Isla Fisher & Blake Ritson Join Al Pacino In John Paul Getty III Kidnapping Pic ‘Captivated’